LifeStance Health (LFST) Gross Profit (2020 - 2024)
LifeStance Health (LFST) has disclosed Gross Profit for 5 consecutive years, with $100.4 million as the latest value for Q3 2024.
- Quarterly Gross Profit rose 31.78% to $100.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $376.3 million through Sep 2024, up 33.68% year-over-year, with the annual reading at $302.1 million for FY2023, 27.46% up from the prior year.
- Gross Profit for Q3 2024 was $100.4 million at LifeStance Health, up from $97.8 million in the prior quarter.
- The five-year high for Gross Profit was $100.4 million in Q3 2024, with the low at $14.2 million in Q2 2020.
- Average Gross Profit over 5 years is $63.6 million, with a median of $60.3 million recorded in 2022.
- The sharpest move saw Gross Profit surged 261.18% in 2021, then rose 15.56% in 2022.
- Over 5 years, Gross Profit stood at $33.1 million in 2020, then surged by 63.72% to $54.2 million in 2021, then grew by 15.56% to $62.7 million in 2022, then skyrocketed by 32.89% to $83.3 million in 2023, then rose by 20.55% to $100.4 million in 2024.
- According to Business Quant data, Gross Profit over the past three periods came in at $100.4 million, $97.8 million, and $94.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.